HUP0102380A2 - Terápiás készítmény hiperkalcémiás krízis kezelésére - Google Patents

Terápiás készítmény hiperkalcémiás krízis kezelésére

Info

Publication number
HUP0102380A2
HUP0102380A2 HU0102380A HUP0102380A HUP0102380A2 HU P0102380 A2 HUP0102380 A2 HU P0102380A2 HU 0102380 A HU0102380 A HU 0102380A HU P0102380 A HUP0102380 A HU P0102380A HU P0102380 A2 HUP0102380 A2 HU P0102380A2
Authority
HU
Hungary
Prior art keywords
remedies
hypercalcemic crisis
hypercalcemic
crisis
pthrp
Prior art date
Application number
HU0102380A
Other languages
English (en)
Inventor
Koh Sato
Toshiaki Tsunenari
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Publication of HUP0102380A2 publication Critical patent/HUP0102380A2/hu
Publication of HUP0102380A3 publication Critical patent/HUP0102380A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgyát terápiás készítmény képezi malignus tumorralkapcsolatos hiperkalcémiás krízis kezelésére, amely aktívösszetevőként pajzsmirigyhormon-szerű protein (PTHrP) és receptoraközti kötődést gátolni képes hatóanyagot tartalmaz. Ó
HU0102380A 1998-06-26 1999-06-25 Remedies for hypercalcemic crisis HUP0102380A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18014398 1998-06-26
PCT/JP1999/003433 WO2000000219A1 (fr) 1998-06-26 1999-06-25 Remedes contre des crises d'hypercalcemie

Publications (2)

Publication Number Publication Date
HUP0102380A2 true HUP0102380A2 (hu) 2001-10-28
HUP0102380A3 HUP0102380A3 (en) 2004-06-28

Family

ID=16078166

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102380A HUP0102380A3 (en) 1998-06-26 1999-06-25 Remedies for hypercalcemic crisis

Country Status (18)

Country Link
EP (1) EP1090643A4 (hu)
KR (1) KR20010083069A (hu)
CN (1) CN1199693C (hu)
AU (1) AU753131B2 (hu)
BR (1) BR9912223A (hu)
CA (1) CA2332128A1 (hu)
CZ (1) CZ20004753A3 (hu)
HK (1) HK1039454B (hu)
HU (1) HUP0102380A3 (hu)
IL (1) IL140387A0 (hu)
MX (1) MXPA00012770A (hu)
NO (1) NO20006603L (hu)
PL (1) PL345117A1 (hu)
RU (1) RU2004137823A (hu)
SK (1) SK19982000A3 (hu)
TR (1) TR200003768T2 (hu)
TW (1) TWI234464B (hu)
WO (1) WO2000000219A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129164A (en) 1996-09-26 2007-05-15 Chugai Pharmaceutical Co Ltd An antibody against peptides associated with human parathyroid hormone
ES2285769T3 (es) 1997-05-15 2007-11-16 Chugai Seiyaku Kabushiki Kaisha Remedio para la caquexia.
ES2569919T3 (es) 1999-04-09 2016-05-13 Kyowa Hakko Kirin Co., Ltd. Procedimiento para controlar la actividad de una molécula inmunofuncional
WO2001002011A1 (fr) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha REMEDES CONTRE LES MALADIES CAUSEES PAR PTH OU PTHrP
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
BR0012467A (pt) * 1999-07-06 2002-06-11 Chugai Pharmaceutical Co Ltd Agente terapêutico para hipercalcemia resistente à droga
JP4516711B2 (ja) * 1999-12-28 2010-08-04 中外製薬株式会社 安定な抗体組成物及び注射製剤
US20030049211A1 (en) * 2000-01-25 2003-03-13 Atsuhiko Kato Remedies and preventives for dental diseases
CA2401357A1 (en) * 2000-02-28 2001-09-07 Chugai Seiyaku Kabushiki Kaisha Tissue degradation inhibitor agent
DE60134962D1 (de) 2000-03-03 2008-09-04 Kyowa Hakko Kogyo Kk Anti-ccr4 antikörper und fragmente davon
JP4846169B2 (ja) 2000-04-28 2011-12-28 中外製薬株式会社 細胞増殖抑制剤
EP1849479A1 (en) * 2000-08-16 2007-10-31 Chugai Seiyaku Kabushiki Kaisha Ameliorating agent for symptoms resulting from joint diseases
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
EP1449850B9 (en) 2001-08-31 2011-05-11 Kyowa Hakko Kirin Co., Ltd. Human cdr-grafted antibodies and antibody fragments thereof
DK1475101T3 (da) 2002-02-14 2011-01-10 Chugai Pharmaceutical Co Ltd Antistof-holdige farmaceutiske opløsninger
EP4259658A1 (en) * 2020-12-10 2023-10-18 Wuxi Biologics Ireland Limited An antibody against p-cadherin and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04228089A (ja) * 1990-05-15 1992-08-18 Kanegafuchi Chem Ind Co Ltd 高カルシウム血症治療・予防剤
CA2087190A1 (en) * 1990-07-13 1992-01-14 Fred E. Cohen Parathyroid hormone analogues modified at positions
JP3504697B2 (ja) * 1993-09-30 2004-03-08 株式会社先端生命科学研究所 ＰＴＨｒＰアンタゴニスト活性を有するポリペプチド及びそれを含むカルシウム代謝治療薬
IL129164A (en) * 1996-09-26 2007-05-15 Chugai Pharmaceutical Co Ltd An antibody against peptides associated with human parathyroid hormone
EP0928365B1 (de) * 1996-09-26 2001-12-19 Siemens Aktiengesellschaft Dampfturbine, dampfturbinenanlage sowie verfahren zur abkühlung einer dampfturbine

Also Published As

Publication number Publication date
BR9912223A (pt) 2001-04-24
NO20006603D0 (no) 2000-12-22
HK1039454A1 (en) 2002-04-26
PL345117A1 (en) 2001-12-03
SK19982000A3 (sk) 2001-11-06
TR200003768T2 (tr) 2001-06-21
IL140387A0 (en) 2002-02-10
MXPA00012770A (es) 2003-07-14
CN1199693C (zh) 2005-05-04
CZ20004753A3 (cs) 2002-06-12
AU753131B2 (en) 2002-10-10
NO20006603L (no) 2001-02-20
RU2004137823A (ru) 2006-06-10
KR20010083069A (ko) 2001-08-31
HK1039454B (zh) 2005-10-21
HUP0102380A3 (en) 2004-06-28
CA2332128A1 (en) 2000-01-06
CN1307485A (zh) 2001-08-08
WO2000000219A1 (fr) 2000-01-06
EP1090643A1 (en) 2001-04-11
EP1090643A4 (en) 2004-05-26
AU4289999A (en) 2000-01-17
TWI234464B (en) 2005-06-21

Similar Documents

Publication Publication Date Title
HUP0102380A2 (hu) Terápiás készítmény hiperkalcémiás krízis kezelésére
WO2001027119A3 (de) Substanzbibliothek enthaltend bicyclische imidazo-5-yl-amine und/oder bicyclische imidazo-3-yl-amine
ZA929919B (en) Powder inhaler.
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
AU5906398A (en) Dosage composition for nasal delivery and method of use of the same
PT1328269E (pt) Associacao de um antagonista do receptor cb1 e de sibutramina composicoes farmaceuticas que os contem e sua utilizacao para o tratamento da obesidade
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
IL132608A0 (en) Fused dihydropyran compounds medicaments containing the same and the use thereof
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
PL367065A1 (en) Use of osteopontin for the treatment and/or prevention of neurologic diseases
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
HUP0104647A2 (hu) Hatóanyagként tilidin-mezilátot tartalmazó, szabályozott hatóanyag-leadású gyógyszerkészítmény
SE9700885D0 (sv) New pharmaceutical formulation
ZA985710B (en) Delayed-release dosage forms of sertraline.
AU2001233913A1 (en) Bcmp 84, a protein associated to breast cancer
IS6087A (is) N-(2-fenýl-4-amínó-bútýl)-1-naftamíð sem virka á móti taugakínín-1 viðtaka
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
HUP9901303A2 (hu) Gyógyszerkészítmény autoimmun betegségek kezelésére
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis
PL368040A1 (en) Substituted 4-aminocyclohexanol derivatives
HK1033876A1 (en) Use of nmda antagonists for treatment of irritablebowel syndrome.
BG106151A (en) Pharmaceutical complex
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
UA32598C2 (uk) Спосіб одержання лікарської форми карбамазепіну

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees